155 related articles for article (PubMed ID: 37385842)
1. Re: Surgery in Early Metastatic Seminoma: A Phase II Trial of Retroperitoneal Lymph Node Dissection for Testicular Seminoma with Limited Retroperitoneal Lymphadenopathy.
Liu J; Thomas B; Lawrentschuk N
Eur Urol; 2023 Oct; 84(4):438-439. PubMed ID: 37385842
[No Abstract] [Full Text] [Related]
2. Surgery in Early Metastatic Seminoma: A Phase II Trial of Retroperitoneal Lymph Node Dissection for Testicular Seminoma With Limited Retroperitoneal Lymphadenopathy.
Daneshmand S; Cary C; Masterson T; Einhorn L; Adra N; Boorjian SA; Kollmannsberger C; Schuckman A; So A; Black P; Bagrodia A; Skinner E; Alemozaffar M; Brand T; Eggener S; Pierorazio P; Stratton K; Nappi L; Nichols C; Luo C; Li M; Hu B
J Clin Oncol; 2023 Jun; 41(16):3009-3018. PubMed ID: 36913642
[TBL] [Abstract][Full Text] [Related]
3. Primary Retroperitoneal Lymph Node Dissection for Seminoma Metastatic to the Retroperitoneum.
Matulewicz RS; Benfante N; Funt SA; Feldman DR; Carver B; Doudt A; Knezevic A; Sheinfeld J
J Urol; 2024 Jan; 211(1):80-89. PubMed ID: 37672753
[TBL] [Abstract][Full Text] [Related]
4. Retroperitoneal Lymph Node Dissection as First-Line Treatment of Node-Positive Seminoma.
Hu B; Shah S; Shojaei S; Daneshmand S
Clin Genitourin Cancer; 2015 Aug; 13(4):e265-e269. PubMed ID: 25682512
[TBL] [Abstract][Full Text] [Related]
5. Robotic Assisted Retroperitoneal Lymph Node Dissection for Small Volume Metastatic Testicular Cancer.
Hiester A; Nini A; Arsov C; Buddensieck C; Albers P
J Urol; 2020 Dec; 204(6):1242-1248. PubMed ID: 32717162
[TBL] [Abstract][Full Text] [Related]
6. Clinical stage II seminoma: management options.
Alsyouf M; Daneshmand S
World J Urol; 2022 Feb; 40(2):343-348. PubMed ID: 34655305
[TBL] [Abstract][Full Text] [Related]
7. Retroperitoneal Lymph Node Dissection in Clinical Stage IIA/B Metastatic Seminoma: Results of the COlogne Trial of Retroperitoneal Lymphadenectomy In Metastatic Seminoma (COTRIMS).
Heidenreich A; Paffenholz P; Hartmann F; Seelemeyer F; Pfister D
Eur Urol Oncol; 2024 Feb; 7(1):122-127. PubMed ID: 37438222
[TBL] [Abstract][Full Text] [Related]
8. Laparoscopic RPLND for clinical stage I nonseminomatous germ cell testicular cancer: current status.
Bhayani SB; Allaf ME; Kavoussi LR
Urol Oncol; 2004; 22(2):145-8. PubMed ID: 15082014
[TBL] [Abstract][Full Text] [Related]
9. Retroperitoneal Lymph Node Dissection as Primary Treatment for Men With Testicular Seminoma: Utilization and Survival Analysis Using the National Cancer Data Base, 2004-2014.
Tabakin AL; Shinder BM; Kim S; Rivera-Nunez Z; Polotti CF; Modi PK; Sterling JA; Farber NJ; Radadia KD; Parikh RR; Kim IY; Saraiya B; Mayer TM; Singer EA; Jang TL
Clin Genitourin Cancer; 2020 Apr; 18(2):e194-e201. PubMed ID: 31818649
[TBL] [Abstract][Full Text] [Related]
10. Midline Extraperitoneal Approach to Retroperitoneal Lymph Node Dissection in Testicular Cancer: Minimizing Surgical Morbidity.
Syan-Bhanvadia S; Bazargani ST; Clifford TG; Cai J; Miranda G; Daneshmand S
Eur Urol; 2017 Nov; 72(5):814-820. PubMed ID: 28325537
[TBL] [Abstract][Full Text] [Related]
11. Post-chemotherapy laparoscopic retroperitoneal lymph node dissection is feasible for stage IIA/B non-seminoma germ cell tumors.
Nakamura T; Kawauchi A; Oishi M; Ueda T; Shiraishi T; Nakanishi H; Kamoi K; Naya Y; Hongo F; Okihara K; Miki T
Int J Clin Oncol; 2016 Aug; 21(4):791-795. PubMed ID: 26701172
[TBL] [Abstract][Full Text] [Related]
12. The Role of Postchemotherapy Surgery in Germ Cell Tumors.
Chéry L; Dash A
Urol Clin North Am; 2015 Aug; 42(3):331-42. PubMed ID: 26216820
[TBL] [Abstract][Full Text] [Related]
13. Robot-assisted post-chemotherapy retroperitoneal lymph node dissection in germ cell tumor: is the single-docking with lateral approach relevant?
Overs C; Beauval JB; Mourey L; Rischmann P; Soulié M; Roumiguié M; Doumerc N
World J Urol; 2018 Apr; 36(4):655-661. PubMed ID: 29353314
[TBL] [Abstract][Full Text] [Related]
14. A systematic review of pN0 testicular seminoma: a new clinical entity and future directions.
Farkouh A; Shete K; Cheng KW; Buell MI; Hu B
Urol Oncol; 2023 Dec; 41(12):476-482. PubMed ID: 37968167
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of post-chemotherapy robot-assisted retroperitoneal lymph node dissection in testicular cancer: multi-institutional study.
Abdul-Muhsin H; Rocco N; Navaratnam A; Woods M; L'Esperance J; Castle E; Stroup S
World J Urol; 2021 Oct; 39(10):3833-3838. PubMed ID: 33959785
[TBL] [Abstract][Full Text] [Related]
16. Indications, evolving technique, and early outcomes with robotic retroperitoneal lymph node dissection.
Werntz RP; Pearce SM; Eggener SE
Curr Opin Urol; 2018 Sep; 28(5):461-468. PubMed ID: 29979235
[TBL] [Abstract][Full Text] [Related]
17. [The surgery after. . . retroperitoneal lymph node dissection and surgery of the residual masses after chemotherapy for advanced testicular cancer].
Guillemin F; Belinga JF; Marchal F; Rauch P; Verhaeghe JL
Bull Cancer; 2011 Jan; 98(1):43-51. PubMed ID: 21300599
[TBL] [Abstract][Full Text] [Related]
18. The role of OCT4 immunohistochemistry in evaluation of retroperitoneal lymph node dissections: a pilot study.
Idrees MT; Williamson SR; Kieffer TW; Cheng L
Mod Pathol; 2013 Dec; 26(12):1613-9. PubMed ID: 23765251
[TBL] [Abstract][Full Text] [Related]
19. Primary Retroperitoneal Lymph Node Dissection in Stage I and Low-volume Metastatic Germ Cell Tumors.
Alsyouf M; Daneshmand S
Eur Urol Focus; 2023 Mar; 9(2):248-250. PubMed ID: 36707277
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of a miRNA-371a-3p Assay for Predicting Final Histopathology in Patients Undergoing Primary Nerve-sparing Retroperitoneal Lymphadenectomy for Stage IIA/B Seminoma or Nonseminoma.
Seelemeyer F; Pfister D; Pappesch R; Merkelbach-Bruse S; Paffenholz P; Heidenreich A
Eur Urol Oncol; 2024 Jun; 7(3):319-322. PubMed ID: 37932157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]